Solventum Corp (SOLV): EPS (Basic)

Annual figures by period end, from SEC filings.

$8.94

Year ended 2025-12-31

+4.7%

3-year compound annual growth

2022-12-31 EPS (Basic) (USD per share) 2025-12-31

Period ended	EPS (Basic)	Change YoY	Source filing
2025-12-31	$8.94	+222.7%	2026-02-27, From 2025-01-01
2024-12-31	$2.77	-64.4%	2026-02-27, From 2024-01-01
2023-12-31	$7.79	+0.1%	2026-02-27, From 2023-01-01
2022-12-31	$7.78	n/a	2025-02-28, From 2022-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Basic)	Change YoY
Solventum Corp (SOLV)	2025-12-31	$8.94	+222.7%
Baxter International Inc (BAX)	2025-12-31	-$1.87	n/m
ResMed Inc (RMD)	2026-06-30	$10.47	+9.6%
Dexcom Inc (DXCM)	2025-12-31	$2.14	+46.6%
Boston Scientific Corp (BSX)	2025-12-31	$1.96	+55.6%
Becton Dickinson & Co (BDX)	2025-09-30	$5.83	-0.9%
MiniMed Group, Inc. (MMED)	2026-04-24	-$1.30	n/m
West Pharmaceutical Services Inc (WST)	2025-12-31	$6.83	+1.2%
Globus Medical Inc (GMED)	2025-12-31	$3.98	+423.7%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗